These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19643321)

  • 21. The COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial: can we deliver on its promise?
    O'Gara PT
    J Am Coll Cardiol; 2010 Mar; 55(13):1359-61. PubMed ID: 20338497
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of contrast media beneficial to angioplasty.
    Dawson P; Strickland N; Allison D
    Diagn Imaging (San Franc); 1991 Feb; 13(2):91-8, 146. PubMed ID: 10149710
    [No Abstract]   [Full Text] [Related]  

  • 23. Potential immunosuppressive effects of statins.
    Kobashigawa JA
    Pediatr Transplant; 2008 Jun; 12(4):381-4. PubMed ID: 18331542
    [No Abstract]   [Full Text] [Related]  

  • 24. Statin therapy for prevention of coronary artery disease. The earlier the better or the longer the better?
    Holdaas H
    Eur Heart J; 2008 Feb; 29(4):425-6. PubMed ID: 18276612
    [No Abstract]   [Full Text] [Related]  

  • 25. Statins: established indications and controversial subgroups.
    Jukema JW; Bergheanu SC
    Heart; 2008 Dec; 94(12):1656-62. PubMed ID: 19011141
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Celik M; Celik T
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):253; author reply 253-4. PubMed ID: 19520663
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
    Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
    J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subclinical atherosclerosis as a target of therapy: potential role of statins.
    Kastelein JJ; Stroes ES; de Groot E
    Am J Cardiol; 2004 Mar; 93(6):737-40. PubMed ID: 15019880
    [No Abstract]   [Full Text] [Related]  

  • 30. Dilemma in the strategy of treatment: revascularization or medical treatment?
    Tatli E; Aktoz M; Aydin G; Yilmaztepe M; Altun A
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):397-8. PubMed ID: 18849243
    [No Abstract]   [Full Text] [Related]  

  • 31. Ask the doctor. I have coronary heart disease. Is this something I can have cured or get rid of, or is keeping it from getting worse the best I can do?
    Lee T
    Harv Heart Lett; 2009 Jan; 19(5):7. PubMed ID: 19575515
    [No Abstract]   [Full Text] [Related]  

  • 32. The inflammation hypothesis and its potential relevance to statin therapy.
    Forrester JS; Libby P
    Am J Cardiol; 2007 Mar; 99(5):732-8. PubMed ID: 17317382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRP and statins for primary prevention of coronary artery disease.
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):97-8; quiz p following 104. PubMed ID: 19078864
    [No Abstract]   [Full Text] [Related]  

  • 34. Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
    Seshasai SR; Ray KK
    Future Cardiol; 2009 Mar; 5(2):129-39. PubMed ID: 19371188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eliminating plaque angiogenesis.
    Koutouzis M; Kyriakides ZS
    J Am Coll Cardiol; 2007 Oct; 50(15):1520-1; author reply 1521. PubMed ID: 17919578
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of restenosis and of cardiac events after coronary angioplasty in diabetics].
    Nyssen A; Legrand V; Scheen AJ
    Rev Med Suisse; 2009 Aug; 5(214):1638-43. PubMed ID: 19772194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does hypercholesterolemia improve operative outcomes in patients without coronary artery disease who undergo cardiac surgery?
    Mascitelli L; Pezzetta F; Goldstein MR
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):256; author reply 256-7. PubMed ID: 19577102
    [No Abstract]   [Full Text] [Related]  

  • 38. What to do when everything has failed: alternative treatment strategies for failure revascularisations.
    Jiménez-Quevedo P; González Ferrer JJ; Perín E
    EuroIntervention; 2009 May; 5 Suppl D():D139-48. PubMed ID: 19736063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. It's time for CHUMP to change.
    Mejia V; Carver JR
    J Invasive Cardiol; 2005 Oct; 17(10):521. PubMed ID: 16204744
    [No Abstract]   [Full Text] [Related]  

  • 40. [Has the time come for hybrid revascularisation in multivessel coronary artery disease?].
    Zembala M; Tajstra M; Zembala M; Filipiak K; Hrapkowicz T; Kalarus Z; Poloński L; Gasior M
    Kardiol Pol; 2009 Jul; 67(7):817-22. PubMed ID: 19650010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.